Thus, the decreased expression of Na +/K+-ATPase subunits, associated with the downregulation of the PI3K/AKT/GSK3β/β-catenin pathway, emerges as a mechanism by which nitroxoline induces antitumor effects in AsPC-1 pancreatic cancer cells. The gene discussed is AKT1; the disease is familial pancreatic carcinoma.